Tammy McDaid describes how she had a panic attack after waking up on Tate's birthday.
Emmerdale star fights back tears over mother’s dementia diagnosis: ‘I’ve never felt so alone’ - ...
GlobalData on MSN
FDA to review Eisai’s Leqembi Iqlik sBLA for Alzheimer’s
The FDA has set a Prescription Drug User Fee Act action date for 24 May 2026.
A longevity researcher shares 9 fruits that are rich in nutrients like antioxidants and fiber to promote healthy aging and ...
BioArctic AB's (publ) (STO: BIOA B) partner Eisai announced today that the supplemental Biologics License Application (sBLA) ...
Homeless New Yorkers languished outside in below-freezing weather Wednesday even as the death toll linked to the unbearable cold hit double-digits – with some claiming the Arctic blast still beats the ...
President Donald Trump has some rather unusual beliefs about exercise, but they might just explain why he has experienced the ...
LEQEMBI is currently approved in 53 countries and regions and is under regulatory review in 7 countries. In August 2025, the US FDA approved LEQEMBI IQLIK 360 mg for weekly subcutaneous maintenance ...
More than 4,400 lawsuits have been filed since millions of Americans embraced GLP-1 drugs like Ozempic, Wegovy and Mounjaro ...
If you break down what we know versus what we don't, the evidence isn't compelling.
If approved, LEQEMBI IQLIK would be the first and only anti-amyloid treatment to offer at-home injection options for initiation and maintenance dosing for this progressive ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results